玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

AZD3514

    
≥98%

AZD3514

源葉(MedMol)
S80214 一鍵復(fù)制產(chǎn)品信息
1240299-33-5
C25H32F3N7O2
519.56
S7040,AZD 3514; 6-(4-{4-[2-(4-acetylpiperazin-1-yl)ethoxy]phenyl}piperidin-1-yl)-3-(trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazine; 1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-[1,2,4]
貨號 規(guī)格 價(jià)格 上海 北京 武漢 南京 購買數(shù)量
S80214-5mg ≥98% ¥555.00 10 - - -
S80214-25mg ≥98% ¥2060.00 10 - - -
S80214-100mg ≥98% ¥5150.00 2 - - -
產(chǎn)品介紹 參考文獻(xiàn) 質(zhì)檢證書(COA) 摩爾濃度計(jì)算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

AZD3514 is an orally activie and selective androgen receptor (AR) inhibitor. AZD3514 androgen-dependently and -independently inhibits AR signal. AZD351 down-regulates nuclear AR levels in human LNCaP prostate cancer cells in the absence of androgen with an pIC50 value of 5.75. AZD3514 can be used for the research of prostate cancer

產(chǎn)品描述: AZD3514 is an orally activie and selective androgen receptor (AR) inhibitor. AZD3514 androgen-dependently and -independently inhibits AR signal. AZD351 down-regulates nuclear AR levels in human LNCaP prostate cancer cells in the absence of androgen with an pIC50 value of 5.75. AZD3514 can be used for the research of prostate cancer
靶點(diǎn): Androgen Receptor;AndrogenReceptor
體內(nèi)研究: AZD3514 (10-100 mg/kg; p.o. once daily for 6 days) inhibits AR signaling in rats. AZD3514 (50 mg/kg; p.o. once daily for 30 days) inhibits prostate tumor growth. AZD3514 (50-100 mg/kg; p.o. once daily for 3 days) significantly reduces nuclear AR protein in vivo
參考文獻(xiàn): 1. Bradbury RH, et al. Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1945-8. 2. Loddick SA, et al. AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo. Mol Cancer Ther. 2013 Sep;12(9):1715-27. 3. Omlin A, et al. AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. Invest New Drugs. 2015 Jun;33(3):679-90.
溶解性: Soluble  in  DMSO
保存條件: -20°C
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 1.925 ml 9.624 ml 19.247 ml
5 mM 0.385 ml 1.925 ml 3.849 ml
10 mM 0.192 ml 0.962 ml 1.925 ml
50 mM 0.038 ml 0.192 ml 0.385 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(COA)

如何獲取質(zhì)檢證書(COA)?
請輸入貨號和一個(gè)與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標(biāo)簽上如何找到貨號和批號?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品

主站蜘蛛池模板: 宿迁市| 鹰潭市| 田东县| 竹北市| 康定县| 兴山县| 凉城县| 宁德市| 南投市| 高淳县| 黄石市| 石渠县| 壤塘县| 左贡县| 庆元县| 新余市| 准格尔旗| 临清市| 肥城市| 镶黄旗| 镇平县| 腾冲县| 黄平县| 虎林市| 石楼县| 宁明县| 东阿县| 奇台县| 九龙县| 广水市| 姚安县| 日喀则市| 兴海县| 灵台县| 藁城市| 东平县| 武陟县| 类乌齐县| 东乌珠穆沁旗| 安福县| 米泉市|